Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics

Grant McGee Talkington, Paresh Kolluru, Timothy E. Gressett, et. al., Frontiers in Neurology One lingering effect of the COVID-19 pandemic created by SARS-CoV-2 is the emergence of Long COVID (LC),…[...]

Read More

Persistent SARS-CoV-2 Spike Protein: Genomic Modulation, Immune Dysregulation, and Impaired Antibody Maturation

Author: John Murphy, CEO COVID 19 Long-haul Foundation Abstract The SARS-CoV-2 spike glycoprotein, central to viral entry and the target of mRNA vaccine platforms, has emerged as a persistent antigen…[...]

Read More

Therapeutic Strategies and Clinical Trials in Long COVID: Anticoagulants, Fibrinolytics, Endothelial Support, Immunomodulators, and RECOVER Protocols

Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is a chronic multisystem condition affecting millions globally. Despite its prevalence, therapeutic options…[...]

Read More

Corticosteroid Strategies in Long COVID: Evaluating Prednisone and Dexamethasone for Persistent Inflammation

John Murphy, The COVID 19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), presents with a constellation of symptoms including fatigue, dyspnea, cognitive dysfunction, and systemic…[...]

Read More

mRNA Vaccination and Arthritis: Etiological Mechanisms, Genomic Susceptibility, Diagnostic Pathways, and Therapeutic Outlook

John Murphy, President The COVID-19 Long-haul Foundation Abstract Messenger RNA (mRNA) vaccines have transformed infectious disease prevention, particularly during the COVID-19 pandemic. While their safety profile is robust, emerging evidence…[...]

Read More